Delivery Order SPE2DB20D1109-SPE2DB25FN97B

Award Date 4/29/25
Potential Completion Date 4/30/25
Potential Value $1.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,714,237 units of Methylphenidate ER 36 mg tablets in 100-count bottles, with a ceiling value of $1,580.90. The contract is a Firm Fixed Price Delivery Order, with a period of performance through March 27, 2025. This contract award is part of a larger Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,566,510,706 units of Methylphenidate ER 18 mg tablets in 100-count packages. The Firm Fixed Price contract, valued at $1,613.35, has a completion date of November 22, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of 4,567,785,629 units of Methylphenidate ER 36 mg tablets in 100-count packages. The contract is a firm fixed-price Delivery Order with a ceiling value of $1,217.04 and an ultimate completion date of April 3, 2025. The contract is not designated as a set-aside award. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB22D1106|SPE2DB25FEJN5, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,968,726 units of Methylphenidate ER 36 mg tablets in 100-count packages, with a firm fixed price of $2,408.00 and a completion date of April 21, 2025. The contract is not set aside and is considered an open competition. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,256.60, is a delivery order for 4,567,988,230 units of the drug Methylphenidate ER 18 mg Tablets in 100-count bottles. The contract has an ultimate completion date of April 23, 2025 and is a firm fixed-price, non-set-aside contract. AmerisourceBergen Drug Corp holds a substantial Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply 4,568,092,582 units of Methylphenidate ER 54 MG tablets in 100-count bottles. The contract is a Delivery Order valued at $1,736.81 with a firm fixed price. It is not a set-aside contract, indicating open competition. The contract has an ultimate completion date of May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp. for the delivery of 4,563,572,523 units of Methylphenidate ER 36 mg tablets in 100-count packages. The contract has a ceiling value of $7,854.07 and a completion date of February 7, 2024. The contract is a Delivery Order under the firm fixed-price pricing type. AmerisourceBergen Drug Corp. is the prime contractor, and there is no set-aside designation indicated for...
This federal contract award, valued at $2,679.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 4,567,988,472 units of the medication Methylphenidate ER 36 mg tablets, with a performance period ending on April 23, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This federal contract award is for the delivery of 4,566,810,759 tablets of Methylphenidate ER 36 mg, a prescription medication, to the Defense Logistics Agency (DLA). The $1,646.73 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 30, 2024, with a completion date of December 31, 2024. This is a delivery order under an Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop...
This federal contract award, valued at $1,144.19, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,568,013,659 units of Methylphenidate ER 36 mg tablets, a prescription medication. This contract has an ultimate completion date of April 24, 2025 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation, indicating open...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB25FN97B
    Delivery Order

This federal contract award, with ID SPE2DB20D1109|SPE2DB25FN97B, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,568,072,487 units of the drug Methylphenidate ER 36 mg tablets in 100-count bottles. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,722.92 and a period of performance through April 30, 2025. The contract was awarded on April 29, 2025 and is not designated as a set-aside.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract positions AmerisourceBergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

Generated 7/29/25, 9:56 AM